Sickle cell disease Sickle cell disease Sickle cell disease (SCD) is a group of blood disorders typically inherited from a person's parents. The most common type is known as sickle cell anaemia (SCA). It results in an abnormality in the oxygen-carrying protein haemoglobin found in red blood cells. This leads to a rigid, sickle-like shape under certain circumstances. Problems in sickle cell disease typically begin around 5 to 6 months of age. A number of health problems may develop, such as attacks of pain ("sickle cell crisis"), anemia, swelling in the hands and feet, bacterial infections and stroke. Long-term pain may develop as
Genetically engineered blood Genetically engineered blood Genetically engineered blood is blood that has been modified for therapeutic or other purposes. Genetically modifying red blood stem cells allows them to produce specific therapeutic proteins on the surface or inside the cell. The stem cells are taken from mammalian bone marrow and are modified in culture. Before they become mature, mammalian red blood cells eject their genetic material. Culturing cells that produce a new protein of interest requires only a few weeks. Using the sortagging protein labeling technique, the researchers used the bacterial enzyme sortase A to establish a strong chemical bond between the surface